IDDI at ARVO Annual Meeting 2023

IDDI’s CEO Linda Danielson will be at this year’s ARVO Annual Meeting from April 23-27 in New Orleans, LA.

Schedule a meeting with Linda to connect and discuss how we can leverage your upcoming ophthalmology drugs or devices development!

WE LOOK FORWARD TO MEETING YOU AT ARVO 2023!

IDDI has long-standing experience in OPHTHALMOLOGY with 160+ trials since inception – IDDI supported Macugen® approval.

• Our valuable therapeutic insight in ophthalmology, paired with data quality expertise, will make a critical difference to the outcome of your clinical trials.
• Our scientific background, experienced teams and in-house therapeutic expertise will provide you with effective study design, start-up and management.
• IDDI’s broad range of expertise is reflected in its expert publications in various medical and statistical journals and through its presence at major meetings and congresses (list provided on request).
• IDDI’s in-depth experience had been gained from involvement in over 1200+ clinical trials across a wide range of therapeutic areas – handling drug, diagnostic and medical device issues, as well as assisting clients in obtaining 21 FDA/EMA approvals.

We are committed to providing quality, submission-ready clinical data, thanks to a unique combination of methodological excellence and operational efficiency.